Bodyport is redefining how heart failure is managed by making early, in-home detection of congestion possible with a single step. Our solution combines the Bodyport Cardiac Scale, which non-invasively measures key hemodynamic biomarkers, with the Congestion Index, an advanced algorithm that accurately predicts worsening heart failure before symptoms escalate. These insights flow into a connected software platform that delivers timely alerts and actionable interventions to patients and care teams. Together, these tools enable earlier treatment, prevent avoidable hospitalizations, and empower people to live healthier, more stable lives.